Navigation Links
Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders
Date:5/29/2008

anticancer treatment. Genta is pursuing a broad clinical development program with Genasense evaluating its potential to treat various forms of cancer.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its DNA/RNA Medicines program. Genta is currently recruiting patients to the AGENDA Trial, a global Phase 3 trial of Genasense in patients with advanced melanoma. The leading drug in Genta's Small Molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. The Company has developed G4544, an oral formulation of the active ingredient in Ganite, that has recently entered clinical trials as a potential treatment for diseases associated with accelerated bone loss. The Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same class of drug as paclitaxel and docetaxel. Ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our website at: http://www.genta.com .

Safe Harbor

This press release may contain forward-looking statements with respect to business conducted by Genta Incorporated. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Forward-looking statements include, without limitation, statements about:

-- the Company's ability to obtain ne
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results
2. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
3. Sexual Function Affected by Stem Cell Transplant According to Long-Term Study
4. Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinsons Disease
5. Horizon Therapeutics Initiates Long-Term Phase 3 Safety Study for Lead Product Candidate HZT-501
6. New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG
7. Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system)
8. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
9. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
10. Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
11. Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 25, 2014  Array BioPharma Inc. (Nasdaq: ... its Chief Executive Officer, Ron Squarer ... conferences.  The public is welcome to participate ... Array BioPharma website:  www.arraybiopharma.com .Event: Piper Jaffray ...  Eastern Time Location: Palace Hotel, New York ...
(Date:11/26/2014)... Nov. 25, 2014 Jazz Pharmaceuticals plc (Nasdaq: ... corporate presentations at two upcoming investor conferences.  , ... on Tuesday, December 2, 2014 at 6:45 a.m. EST ... and head of EUSA International, will provide an overview of the ... Annual Piper Jaffray Healthcare Conference in New York, ...
(Date:11/26/2014)... China , Nov. 26, 2014 / -- China Nepstar Chain ... "Company"), a leading retail drugstore chain in ... operated stores, today announced the appointment of Ms. ... Officer, effective immediately. Ms.Zhang has over ... joined Nepstar in March 1999. Prior to Ms. Zhang,s ...
Breaking Medicine Technology:Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 2China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer 2China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer 3
(Date:11/27/2014)... November 27, 2014 HealthPostures, a ... ergonomics equipment , has announced that it has ... Office Environments. The partnership will put HealthPostures' products ... location. , In addition to having its products ... partnership promotes HealthPostures' products with the business decision ...
(Date:11/27/2014)... At The Little Gym, we know ... as no surprise when a recent study confirmed that ... The Journal of Pediatrics found that “Promoting ... during the school years may be important not only ... study monitored two groups of children; those that were ...
(Date:11/27/2014)... New Delhi, India (PRWEB) November 27, 2014 ... internet marketing company, has announced online reputation management ... after doing a comprehensive study about the world of ... Google, Bing, and Yahoo. , Ethane Web Technologies ... project. Instead, it first analyzes the project to reach ...
(Date:11/27/2014)... VeloReality Inc. President Gary Bauer ... Videos (RLVs) of world-famous velo courses for the company's VRide ... other popular indoor velo trainers. Two dozen additional Real Life ... end of November -- in time for the 2014 ... rides in the VeloReality collection to over sixty. , The ...
(Date:11/27/2014)... Serious Buyer, Andrew Hawley from Vintage Rock ... Memorial Coliseum concert posters. Between 1969 and 1977 many ... of Alabama. Jimi Hendrix started the concert series on ... Gary Weinberger who was a freshman at the University ... council was responsible for bringing music acts to the ...
Breaking Medicine News(10 mins):Health News:Ergonomics Manufacturer Announces New Partnership with Office Supply Dealer 2Health News:Ethane Web Technologies Announces Online Reputation Management Service 2Health News:Winter 2015 Weather Forecast Is Warm and Dry For VeloReality Riders With New RLV Offering 2Health News:Winter 2015 Weather Forecast Is Warm and Dry For VeloReality Riders With New RLV Offering 3Health News:Serious Buyer Announces His Search For Vintage 1969 Jimi Hendrix Tuscaloosa Memorial Coliseum Concert Posters 2
... Oct. 22 , Deadline: October 31, 2007 ... American Academy of Allergy, Asthma & Immunology (AAAAI), ... States,representing allergists, asthma specialists, clinical immunologists, allied,health professionals ... research and,treatment of allergic disease, is now accepting ...
... people gathered on,Tuesday, October 9, at The Ritz-Carlton Dearborn ... CATCH Night of Champions. The event,featured a dinner, live ... raised $225,000, with more than $38,000 raised by the ... major supporter of the charity since,1989, and title sponsor ...
... would make all the difference, report finds , , MONDAY, ... could be saved by a coordinated global effort to ... cleaner household fuels in underdeveloped countries, a new study ... the lives of almost 1.5 million children in sub-Saharan ...
... JACKSONVILLE, Fla. − A vaccine that has significantly increased ... multiforme (GBM) − the most common, most aggressive form ... offered through a clinical trial at Mayo Clinic in ... simple approach to treating this cancer, says neurosurgeon Kent ...
... recognize technology innovation for healthcare., CHICAGO and ... Group (MS-HUG) and Microsoft Corp. today,announced a call ... The contest, open to any healthcare organization, recognizes,leadership ... quality and delivery of,healthcare. (Logo: http://www.newscom.com/cgi-bin/prnh/20000822/MSFTLOGO ...
... donors increased their charitable contributions to health care,facilities and ... $7.9,billion was substantially lower than the 16 percent rate ... a new "Report on Giving" issued today,by The Association ... eroded and the health care system is,being stressed by ...
Cached Medicine News:Health News:Call for Entries: 2007 AAAAI Annual Samter Journalism Awards 2Health News:Saving Millions of Children's Lives Is Possible 2Health News:Mayo Clinic tests novel vaccine for aggressive brain tumors 2Health News:Call for Entries Announced for 2008 MS-HUG Innovation Awards 2Health News:Call for Entries Announced for 2008 MS-HUG Innovation Awards 3Health News:Philanthropic Giving for Health Care Slows in 2006 in both U.S. and Canada, According to Association for Healthcare Philanthropy's Annual 'Report on Giving' 2Health News:Philanthropic Giving for Health Care Slows in 2006 in both U.S. and Canada, According to Association for Healthcare Philanthropy's Annual 'Report on Giving' 3
... Cauteries provide a broad selection of ... wide variety of ophthalmic procedures. Each ... complete with a safety cap to ... position when not in use, and ...
... a broad selection of tip styles ... of ophthalmic procedures. Each single use ... a safety cap to lock switch ... not in use, and carries a ...
... Accu-Temp Cauteries provide a broad selection ... a wide variety of ophthalmic procedures. ... sterile, complete with a safety cap ... " position when not in use, ...
... Luminary LASIK Light Probes provide the surgeon ... the corneal interface to be easily visualized ... the Tindal effect and light scatter technique, ... debris, epithelial deposits, flap edge folds, corneal ...
Medicine Products: